Central Nervous System Metastases in Lung Cancer Patients: From Prevention to Diagnosis and Treatment
Approximately 40% of lung cancer patients will develop central nervous system (CNS) metastases during the course of their disease. Most of these are brain metastases, but up to 10% will develop leptomeningeal metastases. Known risk factors for CNS metastases development are small cell lung cancer (S...
Format: | eBook |
---|---|
Language: | English |
Published: |
Frontiers Media SA
2019
|
Series: | Frontiers Research Topics
|
Subjects: | |
Online Access: | Open Access: DOAB: description of the publication Open Access: DOAB, download the publication |
Similar Items
-
Editorial: Central Nervous System Metastases in Lung Cancer Patients: From Prevention to Diagnosis and Treatment
by: Lizza E. L. Hendriks, et al.
Published: (2018-11-01) -
Research Progress of Lung Cancer with Leptomeningeal Metastasis
by: Chunhua MA, et al.
Published: (2014-09-01) -
Findings to Leptomeningeal Metastases in Lung Cancer: A Case Report
by: Thiago Rodrigo de Noronha, et al.
Published: (2019-01-01) -
Management of Leptomeningeal Metastases in Non-oncogene Addicted Non-small Cell Lung Cancer
by: Ana Turkaj, et al.
Published: (2018-07-01) -
Interpretation of China Experts Consensus on the Diagnosis and Treatment of Brain Metastases of Lung Cancer (2017 Version)
by: Xin-en HUANG
Published: (2017-03-01)